A randomized trial comparing time intervals from HCG trigger to intrauterine insemination for cycles utilizing GnRH antagonists

References

• Aydin, Y., Hassa, H., Oge, T. and Tokgoz, V.Y. (2013) A randomized study of simultaneous hCG administration with intrauterine insemination in stimulated cycles. Eur J Obstet Gynecol Reprod Biol 170:444–8
   Google Scholar
• Bakas, P., Konidaris, S., Liapis, A., Gregoriou, O., Tzanakaki, D. and Creatsas, G. (2011) Role of gonadotropin-releasing hormone antagonist in the management of subfertile couples with intrauterine insemination and controlled ovarian stimulation. Fertil Steril 95:2024–8
   PubMed Web of Science ®Google Scholar
• Blockeel, C., Knez, J., Polyzos, N.P., De Vos, M., Camus, M. and Tournaye, H. (2014) Should an intrauterine insemination with donor semen be performed 1 or 2 days after the spontaneous LH rise? A prospective RCT. Human Reproduction 29:697–703
   PubMed Web of Science ®Google Scholar
• Cantineau, A.E., Cohlen, B.J. and Dutch IUI Study Group. (2007) The prevalence and influence of luteinizing hormone surges in stimulated cycles combined with intrauterine insemination during a prospective cohort study. Fertil Steril 88:107–12
   Google Scholar
• Cantineau, A.E., Cohlen, B.J., Klip, H., Heineman, M.J. and Dutch IUI Study Group Collaborators. (2011) The addition of GnRH antagonists in intrauterine insemination cycles with mild ovarian hyperstimulation does not increase live birth rates–a randomized, double-blinded, placebo-controlled trial. Hum Reprod 26:1104–11
   PubMed Web of Science ®Google Scholar
• Chaffkin, L.M., Nulsen, J.C., Luciano, A.A. and Metzger, D.A. (1991) A comparative analysis of the cycle fecundity rates associated with combined human menopausal gonadotropin (hMG) and intrauterine insemination (IUI) versus either hMG or IUI alone. Fertil Steril 55:252–7
   PubMed Web of Science ®Google Scholar
• Checa, M.A., Prat, M., Robles, A. and Carreras, R. (2006) Use of gonadotropin-releasing hormone antagonists to overcome the drawbacks of intrauterine insemination on weekends. Fertil Steril 85:573–7
   PubMed Web of Science ®Google Scholar
• Claman, P., Wilkie, V. and Collins D. (2004) Timing intrauterine insemination either 33 or 39 hours after administration of human chorionic gonadotropin yields the same pregnancy rates as after superovulation therapy. Fertil Steril 82:13–16
   PubMed Web of Science ®Google Scholar
• Dickey, R.P., Taylor, S.N., Lu, P.Y., Sartor, B.M., Rye, P.H. and Pyrzak, R. (2005) Risk factors for high-order multiple pregnancy and multiple birth after controlled ovarian hyperstimulation: results of 4,062 intrauterine insemination cycles. Fertil Steril 83:671–83
   PubMed Web of Science ®Google Scholar
• Dong, F., Sun, Yp., Su, Yc., Guo, Yh., Hu, L.l. and Wang, F. (2011) Relationship between processed total motile sperm count of husband or donor semen and pregnancy outcome following intrauterine insemination. Syst Biol Reprod Med 57:251–5
   PubMed Web of Science ®Google Scholar
• Duran, H.E., Morshedi, M., Kruger, T. and Oehninger, S. (2002) Intrauterine insemination: a systematic review on determinants of success. Hum Reprod Update 8:373–84
   PubMed Web of Science ®Google Scholar
• Erdem, A., Erdem, M., Atmaca, S., Korucuoglu, U. and Karabacak, O. (2008) Factors affecting live birth rate in intrauterine insemination cycles with recombinant gonadotrophin stimulation. Reprod Biomed Online 17:199–206
   PubMedGoogle Scholar
• Ertunc, D., Tok, E.C., Savas, A., Ozturk, I., and Dilek, S. (2010) Gonadotropin-releasing hormone antagonist use in controlled ovarian stimulation and intrauterine insemination cycles in women with polycystic ovary syndrome. Fertil Steril 93:1179–84
   Google Scholar
• Eshre position paper. Good clinical treatment in assisted reproduction. 2008. website:http://www.eshre.eu/~/media/emagic%
   Google Scholar
• Ferraretti, A.P., Goossens, V., de Mouzon, J., Bhattacharya, S., Castilla, J.A., Korsak, V., et al. (2012) Assisted reproductive technology in Europe, 2008: results generated from European registers by ESHRE. Hum Reprod 27:2571–84
   PubMed Web of Science ®Google Scholar
• Ghanem, M.E., Bakre, N.I., Emam, M.A., Al Boghdady, L.A., Helal, A.S., Elmetwally, A.G., et al. (2011) The effects of timing of intrauterine insemination in relation to ovulation and the number of inseminations on cycle pregnancy rate in common infertility etiologies. Hum Reprod 26:576–83
   PubMed Web of Science ®Google Scholar
• Gleicher, N., Oleske, D.M., Tur-Kaspa, I., Vidali, A. and Karande, V. (2000) Reducing the risk of high-order multiple pregnancy after ovarian stimulation with gonadotropins. N Engl J Med 343:2–7
   PubMed Web of Science ®Google Scholar
• Guzick, D.S. (2004) For now, one well-timed intrauterine insemination is the way to go. Fertil Steril 82:30–1
   Google Scholar
• Guzick, D.S., Carson, S.A., Coutifaris, C., Overstreet, J.W., Factor-Litvak, P., Steinkampf, M.P., et al. (1999) Efficacy of superovulation and intrauterine insemination in the treatment of infertility. National Cooperative Reproductive Medicine Network N Engl J Med 340:177–83
   PubMed Web of Science ®Google Scholar
• Kosmas, I.P., Tatsioni, A., Kolibianakis, E.M., Verpoest, W., Tournaye, H. and Van der Elst, J. (2008) Effects and clinical significance of GnRH antagonist administration for IUI timing in FSH superovulated cycles: a meta-analysis. Fertil Steril. 90:367–72
   PubMed Web of Science ®Google Scholar
• la Cour Freiesleben, N., Lossl, K., Bogstad, J., Bredkjaer, H.E., Toft, B., Rosendahl, M., et al. (2009) Individual versus standard dose of rFSH in a mild stimulation protocol for intrauterine insemination: a randomized study. Hum Reprod 24:2523–30
   Google Scholar
• Matorras, R., Ramón, O., Expósito, A., Corcóstegui, B., Ocerin, I., Gonzalez-Lopera, S., et al. (2006) Gn-RH antagonists in intrauterine insemination: the weekend-free protocol. J Assist Reprod Genet 23:51–4
   PubMed Web of Science ®Google Scholar
• Merviel, P., Heraud, M.H., Grenier, N., Lourdel, E., Sanguinet, P. and Copin, H. (2010) Predictive factors for pregnancy after intrauterine insemination (IUI): an analysis of 1038 cycles and a review of the literature. Fertil Steril 93:79–88
   PubMed Web of Science ®Google Scholar
• Nulsen, J.C., Walsh, S., Dumez, S. and Metzger, D.A. (1993) A randomized and longitudinal study of human menopausal gonadotropin with intrauterine insemination in the treatment of infertility. Obstet Gynecol 82:780–6
   PubMed Web of Science ®Google Scholar
• Quaas, A.M., Missmer, S.A. and Ginsburg, E.S. (2010) Gonadotropin-releasing hormone antagonist use is associated with increased pregnancy rates in ovulation induction-intrauterine insemination to in vitro fertilization conversions, independent of age and estradiol level on the day of human chorionic gonadotropin administration. Fertil Steril 93:605–8
   Google Scholar
• Ragni, G., Caliari, I., Nicolosi, A.E., Arnoldi, M., Somigliana, E. and Crosignani, P.G. (2006) Preventing high-order multiple pregnancies during controlled ovarian hyperstimulation and intrauterine insemination: 3 years' experience using low-dose recombinant follicle-stimulating hormone and gonadotropin-releasing hormone antagonists. Fertil Steril 85:619–24
   Google Scholar
• Ragni, G., Somigliana, E. and Vegetti, W. (2004) Timing of intrauterine insemination: where are we? Fertil Steril 82:25–6
   PubMed Web of Science ®Google Scholar
• Testart, J. and Frydman, R. (1982) Minimum time lapse between luteinizing hormone surge or human chorionic gonadotropin administration and follicular rupture. Fertil Steril 37:50–3
   PubMed Web of Science ®Google Scholar
• Tournaye, H., Verheyen, G., Albano, C., Camus, M., Van Landuyt, L., Devroey, P. and Van Steirteghem, A. (2002) Intracytoplasmic sperm injection versus in vitro fertilization: a randomized controlled trial and a meta-analysis of the literature. Fertil and Steril 78:1030–7
   PubMed Web of Science ®Google Scholar
• van Rumste, M.M., Custers, I.M., van der Veen, F., van Wely, M., Evers, J.L. and Mol, B.W. (2008) The influence of the number of follicles on pregnancy rates in intrauterine insemination with ovarian stimulation: a meta-analysis. Hum Reprod Update 14:563–70
   PubMed Web of Science ®Google Scholar
• Weiss, A., Beck Fruchter, R., Lavee, M. and Geslevich, Y. (2014) Can Gonadotropins be Safely Used in Stimulated IUI Cycles or Ovulation Induction? Presented at the Israeli Fertility Association Annual Meeting, Tel-Aviv, Israel
   Google Scholar
• Wilcox, A., Weinberg, C. and Baird, D. (1995) Timing of sexual intercourse in relation to ovulation—effects on the probability of conception, survival of the pregnancy, and sex of the baby. N Engl J Med 333:1517–21
   PubMed Web of Science ®Google Scholar
• Zikopoulos, K., Kaponis, A., Adonakis, G., Sotiriadis, A., Kalantaridou, S., Georgiou, I., et al. (2005) A prospective randomized study comparing gonadotropin-releasing hormone agonists or gonadotropin-releasing hormone antagonists in couples with unexplained infertility and/or mild oligozoospermia. Fertil Steril 83:1354–62
   PubMedGoogle Scholar